EGFR and non-small cell lung carcinoma: The most common genetic alterations in NSCLC are Kirsten rat sarcoma (KRAS) and epidermal growth factor receptor (EGFR) genes, which contribute to the resistance of certain targeted inhibitors (3, 4).